Cargando…
Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone—Results from a randomized controlled trial
BACKGROUND: Low cortisol levels are associated with several functional pain syndromes. In patients with secondary adrenal insufficiency (SAI), the lack in endogenous cortisol production is substituted by the administration of oral hydrocortisone (HC). Our previous study showed that a lower dose of H...
Autores principales: | Werumeus Buning, Jorien, Konopka, Karl-Heinz, Brummelman, Pauline, Koerts, Janneke, Dullaart, Robin P. F., van den Berg, Gerrit, van der Klauw, Melanie M., Tucha, Oliver, Wolffenbuttel, Bruce H. R., van Beek, André P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501533/ https://www.ncbi.nlm.nih.gov/pubmed/28686664 http://dx.doi.org/10.1371/journal.pone.0180326 |
Ejemplares similares
-
Higher hydrocortisone dose increases bilirubin in hypopituitary patients‐ results from an RCT
por: Werumeus Buning, Jorien, et al.
Publicado: (2016) -
Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency
por: Bannon, Christopher A. M., et al.
Publicado: (2021) -
Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency
por: Guarnotta, V, et al.
Publicado: (2019) -
Metabolic Effects of Cortisone Acetate vs Hydrocortisone in Patients With Secondary Adrenal Insufficiency
por: Ekstrand, Elise, et al.
Publicado: (2020) -
Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency
por: Bioletto, Fabio, et al.
Publicado: (2023)